Tessel's contributions to the CATALYST program will accelerate the use of New Approach Methodologies (NAMs) for safer drug development through simulation. This work will also broaden the scope of ...
Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating ...
A new chemical method that could speed up the creation of medicines, materials and products people rely on every day has been ...
An international research team from the Leibniz Institute for Catalysis (LIKAT) has developed a novel, environmentally ...
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and ...